Skip to main content

18 Result(s)

within G. Masera Remove this filter Internal Medicine Remove this filter

and

  1. Article

    Open Access

    Possible role of pandemic AH1N1 swine flu virus in a childhood leukemia cluster

    G Cazzaniga, L Bisanti, G Randi, S Deandrea, S Bungaro, F Pregliasco, D Perotti… in Leukemia (2017)

    Download PDF (660 KB) View Article

  2. No Access

    Article

    Detection of PICALM-MLLT10 (CALM-AF10) and outcome in children with T-lineage acute lymphoblastic leukemia

    L Lo Nigro, E Mirabile, M Tumino, C Caserta, G Cazzaniga, C Rizzari… in Leukemia (2013)

  3. Article

    ‘Educational symposium on long-term results of large prospective clinical trials for childhood acute lymphoblastic leukemia (1985–2000)’

    M Schrappe, J Nachman, S Hunger, K Schmiegelow, V Conter, G Masera, R Pieters… in Leukemia (2010)

    Download PDF (119 KB) View Article

  4. No Access

    Article

    Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia

    We analyzed the long-term outcome of 4865 patients treated in Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia (ALL) of the Italian Association of Pediatric Hematology and Oncology (AIE...

    V Conter, M Aricò, G Basso, A Biondi, E Barisone, C Messina, R Parasole… in Leukemia (2010)

  5. No Access

    Article

    The Eleventh International Childhood Acute Lymphoblastic Leukemia Workshop Report: Ponte di Legno, Italy, 6–7 May 2009

    A Biondi, A Baruchel, S Hunger, G Masera, K Schmiegelow, M Schrappe, C H Pui in Leukemia (2009)

  6. No Access

    Article

    Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia

    Detection of minimal residual disease (MRD) is the most sensitive method to evaluate treatment response and one of the strongest predictors of outcome in childhood acute lymphoblastic leukemia (ALL). The 10-ye...

    T Flohr, A Schrauder, G Cazzaniga, R Panzer-Grümayer, V van der Velden… in Leukemia (2008)

  7. No Access

    Article

    Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting

    Minimal residual disease (MRD) diagnostics is used for treatment stratification in childhood acute lymphoblastic leukemia. We aimed to identify and solve potential problems in multicenter MRD studies to achiev...

    V H J van der Velden, E R Panzer-Grümayer, G Cazzaniga, T Flohr, R Sutton… in Leukemia (2007)

  8. No Access

    Article

    The eighth international childhood acute lymphoblastic leukemia workshop (‘Ponte di Legno meeting’) report: Vienna, Austria, April 27–28, 2005

    The International Acute Lymphoblastic Leukemia Working Group, the so-called ‘Ponte di Legno Workshop’ has led to substantial progress in international collaboration in leukemia research. On April 27–28, 2005, ...

    H Gadner, G Masera, M Schrappe, T Eden, Y Benoit, C Harrison, J Nachman… in Leukemia (2006)

  9. No Access

    Article

    The Seventh International Childhood Acute Lymphoblastic Leukemia Workshop Report: Palermo, Italy, January 29–30, 2005

    Between 1995 and 2004, six International Childhood Acute Lymphoblastic Leukemia (ALL) Workshop have been held, and the completion of several collaborative projects has established the clinical relevance and tr...

    M Aricó, A Baruchel, Y Bertrand, A Biondi, V Conter, T Eden, H Gadner, P Gaynon… in Leukemia (2005)

  10. No Access

    Article

    Ponte di Legno Working Group: statement on the right of children with leukemia to have full access to essential treatment and report on the Sixth International Childhood Acute Lymphoblastic Leukemia Workshop

    The Sixth International Childhood ALL Workshop was made possible by unrestricted educational grants from Sanofi-Synethelabo Inc., Glaxosmithkline, Enzon Inc., and Ilex. Preparation of the Meeting Report was su...

    C-H Pui, M Schrappe, G Masera, J Nachman, H Gadner, O B Eden, W E Evans… in Leukemia (2004)

  11. No Access

    Article

    Gene expression profile unravels significant differences between childhood and adult Ph+ acute lymphoblastic leukemia

    C A Scrideli, G Cazzaniga, G Fazio, L Pirola, A Callegaro, R Bassan, A Rambaldi… in Leukemia (2003)

  12. No Access

    Article

    Allogeneic bone marrow stem cell transplantation following CD34+ immunomagnetic enrichment in patients with inherited metabolic storage diseases

    T-cell depletion is an essential step in reducing the risk of graft-versus-host disease (GVHD) in patients with inherited metabolic storage diseases (IMSD) undergoing hematopoietic stem cell transplantation. T...

    G Gaipa, M Dassi, P Perseghin, N Venturi, P Corti… in Bone Marrow Transplantation (2003)

  13. No Access

    Article

    Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements

    To assess the clinical heterogeneity among patients with acute lymphoblastic leukemia (ALL) and various 11q23 abnormalities, we analyzed data on 497 infants, children and young adults treated between 1983 and ...

    C-H Pui, J M Chessells, B Camitta, A Baruchel, A Biondi, J M Boyett, A Carroll… in Leukemia (2003)

  14. No Access

    Article

    ‘Ponte di Legno’ Working Group – Report on the Fifth International Childhood Acute Lymphoblastic Leukemia Workshop: Vienna, Austria, 29 April – 1 May 2002

    H Gadner, O A Haas, G Masera, C-H Pui, M Schrappe in Leukemia (2003)

  15. No Access

    Article

    International childhood Acute Lymphoblastic Leukemia workshop: Sausalito, CA, 30 November–1 December 2000

    C-H Pui, S Sallan, MV Relling, G Masera, WE Evans in Leukemia (2001)

  16. No Access

    Article

    Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Acute Lymphoblastic Leukemia Studies, 1982–1995

    The first multicentric approach to childhood acute lymphoblastic leukemia (ALL) treatment in Italy started in the early 1970s when the Associazione Italiana di Ematologia ed Oncologia Pediatrica (AIEOP) was fo...

    V Conter, M Aricò, MG Valsecchi, G Basso, A Biondi, E Madon, F Mandelli… in Leukemia (2000)

  17. No Access

    Article

    Clonal stability in children with acute lymphoblastic leukemia (ALL) who relapsed five or more years after diagnosis

    Although most relapses of childhood acute lymphoblastic leukemia (ALL) occur 24–36 months after first CR has been achieved, few patients relapse 5 or more years after CR achievement. The assessment of clonalit...

    L Lo Nigro, G Cazzaniga, A Di Cataldo, A Pannunzio, E D'Aniello, G Masera… in Leukemia (1999)

  18. No Access

    Article

    Autologous bone marrow transplantation for treatment of isolated central nervous system relapse of childhood acute lymphoblastic leukemia

    The purpose of this study was to assess the role of ABMT in children with ALL who are in 2nd CR after an early isolated CNS relapse. All children experiencing an isolated CNS relapse at 10 AIEOP centers (Assoc...

    C Messina, MG Valsecchi, M Aricò, F Locatelli, F Rossetti… in Bone Marrow Transplantation (1998)